About a week after the FDA postponed a meeting to discuss HRA Pharma's birth control pill for over-the-counter use, 21 attorneys general penned a letter to urge the regulator to approve of an option that's safe and effective.
"Access to OTC birth control is more important than ever," the letter said.
The coalition, which was led by California Attorney General Rob Bonta, said an approved over-the-counter birth control drug would remove barriers to reproductive care and help prevent unwanted pregnancies.
HRA Pharma submitted an over-the-counter drug application for its contraceptive drug Opill in mid-July, and the original FDA committee meeting date was Nov. 18 until the agency rescheduled it "to review additional information." No date has been given yet, but if Opill is approved for over-the-counter use, it will be the first birth control pill to not require a prescription.